These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38682208)

  • 1. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
    Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
    Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsaicin enhances cisplatin-induced anti-metastasis of nasopharyngeal carcinoma by inhibiting EMT and ERK signaling via serpin family B member 2.
    Xu Y; Kong W; Zhao S; Xiong D; Wang Y
    Carcinogenesis; 2024 Aug; 45(8):556-568. PubMed ID: 38756095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evodiamine inhibits proliferation and induces apoptosis of nasopharyngeal carcinoma cells via the SRC/ERBB2-mediated MAPK/ERK signaling pathway.
    Liu J; He L; Zhang W; Tang Y; Fan J; He Y
    J Transl Med; 2024 Sep; 22(1):859. PubMed ID: 39334374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway.
    Wu S; Cai W; Shi Z; Ming X; Yang X; Zhou Y; Chen X; Yang M
    Biochem Biophys Res Commun; 2022 Jul; 614():47-55. PubMed ID: 35567943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma.
    Chiang C; Zhang M; Wang D; Xiao T; Zhu L; Chen K; Huang J; Huang J; Zhu J; Li L; Chen C; Chen Y; Hu H; Jiang W; Zou Y; Wang T; Zheng D
    Theranostics; 2020; 10(17):7906-7920. PubMed ID: 32685028
    [No Abstract]   [Full Text] [Related]  

  • 7. STRESS granule-associated RNA-binding protein CAPRIN1 drives cancer progression and regulates treatment response in nasopharyngeal carcinoma.
    Yang T; Huang L; Qin H; Mai S
    Med Oncol; 2022 Dec; 40(1):47. PubMed ID: 36515758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
    Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
    J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.
    Luo S; Huang G; Wang Z; Wan Z; Chen H; Liao D; Chen C; Li H; Li B; Chen L; Huang Z; He Z
    Int J Clin Exp Pathol; 2015; 8(9):9990-10001. PubMed ID: 26617707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydrocrenatidine extracted from
    Hsieh MC; Lo YS; Chuang YC; Lin CC; Ho HY; Hsieh MJ; Lin JT
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 13. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.
    Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X
    Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 13 promotes radiotherapy sensitivity of nasopharyngeal carcinoma by downregulating the MEK/ERK pathway.
    Shi M; Wan J; Wang H; Yu H
    IUBMB Life; 2022 Jun; 74(6):543-553. PubMed ID: 35426961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Inhibits Nasopharyngeal Carcinoma (NPC) by Targeting the MAPK Signaling Pathway.
    Yi Y; Zhou B; Man T; Xu Z; Tang H; Li J; Sun Z
    Anticancer Agents Med Chem; 2024; 24(16):1207-1219. PubMed ID: 38988166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Suppresses Human Nasopharyngeal Carcinoma Cell Growth Via Inhibiting Differentiation Antagonizing Non-Protein Coding RNA (DANCR) Expression.
    Zhang J; Jin X; Zhou C; Zhao H; He P; Hao Y; Dong Q
    Med Sci Monit; 2020 Jul; 26():e923622. PubMed ID: 32683392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific super-enhancer actuated by berberine regulates EGFR-mediated RAS-RAF1-MEK1/2-ERK1/2 pathway to induce nasopharyngeal carcinoma autophagy.
    Wu Y; Jia Q; Tang Q; Chen L; Deng H; He Y; Tang F
    Cell Mol Biol Lett; 2024 Jun; 29(1):92. PubMed ID: 38943090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
    Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma.
    Liu YT; Hsieh MJ; Lin JT; Chen G; Lin CC; Lo YS; Chuang YC; Hsi YT; Chen MK; Chou MC
    Biomed Pharmacother; 2019 Mar; 111():262-269. PubMed ID: 30590314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.